Search Medical Condition
Please enter condition
Please choose location from dropdown

Clostridium Difficile-Associated Diarrhea Clinical Trials

A listing of Clostridium Difficile-Associated Diarrhea medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (15) clinical trials

Is another Clostridium difficile infection getting in the way of your life? Consider this medical research study of an investigational medication that may help prevent these infections from recurring.

Phase N/A

Wake Research Associates is enrolling volunteers with C. Diff in a study testing the effectiveness, tolerability and safety of an investigational medication for this condition. Some of the symptoms of C. diff infection include: Watery diarrhea, up to 15 times each day Severe abdominal pain Loss of appetite Fever Blood ...

Phase N/A

Qualified participants will receive at no cost to them: study medications study-related labs physicals and exams compensation for your time and travel for each visit

Phase N/A

The Clover trial is evaluating an investigational vaccine that may help to prevent Clostridium difficile infection. Participants in the study are adults 50 years of age and older, who are at risk of developing Clostridium difficile infection. The study will assess whether the vaccine prevents the disease, and whether it ...

Phase

Individuals most at-risk for C. diff have a generally weakened condition, have received antibiotics, and are likely to have been hospitalized or residing in Long Term Care Facilities. Clostridium difficile (C-diff) is a potentially deadly, spore-forming bacterium emerging as the leading cause of life-threatening, healthcare-associated infections worldwide. C.diff toxins cause ...

Phase

The aim of this study is to evaluate the efficacy of the candidate Clostridium difficile (C. difficile) vaccine to prevent primary symptomatic C. difficile infection (CDI) in subjects a risk for CDI where there is a substantial unmet medical need.

Phase

If you answer "Yes" to the Eligiblity Criteria, you may be at risk for a serious healthcare associated infection from a bacterium called Clostridium Difficile (C. diff) Sanofi Pasteur and this research site are conducting a clinical research study for an investigational vaccine that may protect at risk individuals like ...

Phase N/A

The purpose of this study is to assess safety and efficacy of study medication in reducing recurrence of Clostridium Difficile Infection (CDI) in adults who had a CDI recurrence.

Phase N/A

ECOSPOR III is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the safety, tolerability, and efficacy of SER-109 versus placebo in adult subjects 18 years of age or older with recurrent CDI  

Phase

A research study is evaluating an investigational medication for adults with recurrent Clostridium difficile (C. diff) infection. The study is seeking to find out if the study medication helps reduce the risk of recurring infections.  

Phase N/A